Eli Lilly’s post-earnings decline is creating a buying opportunity for long-term investors
Club holding Eli Lilly's (LLY) post-earnings sell-off is creating a buying opportunity Thursday. Our long-term conviction is not shaken. Source
Read moreClub holding Eli Lilly's (LLY) post-earnings sell-off is creating a buying opportunity Thursday. Our long-term conviction is not shaken. Source
Read moreEvusheld was a key antibody treatment taken by people with weak immune systems as an added layer of protection. Source
Read moreMartin Shkreli, who was released from prison last year, had been banned "for life" from the drug business as a
Read moreThe year ahead is pivotal for Eli Lilly (LLY) as the pharmaceutical giant advances its stellar drug pipeline. Source link
Read moreRepublican George Santos is facing criticisms from the Nassau County Republican Committee as he's under scrutiny for embellishing and lying
Read moreBeijing on Monday dropped its quarantine on arrival policy, leading many to book their first overseas trips in years. Source
Read moreAdvancements in base business are helping quell fears of what will happen in a Covid trough. Source link
Read moreDrugstores are warning of shortages of key antibiotics used to treat Strep A, as cases rise in the U.K. Source
Read moreCostco Wholesale (COST), Amazon (AMZN), Humana (HUM) and Bausch Health (BHC) are the stocks, and two of them are higher
Read more